IP Library Granted Patent US 8,142,817
Granted Patent B2
US 8,142,817 · App. 12/218,334 · Granted Mar 27, 2012

Composition for restoration of age related tissue loss in the face or selected areas of the body

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,142,817
App. No.
12/218,334
Granted
Mar 27, 2012
Kind
B2
Abstract

A treatment method for restoring of age related tissue loss in the face or selected areas of the body is disclosed which includes injecting an injectable composition containing a growth factor and hyaluronic acid as a carrier into the dermis, the hypodermis, or both, in various areas of the face, or selected areas of the body of a person to stimulate collagen, elastin, or fat cell production, thereby restoring age related tissue loss in the face and selected areas of the body. Further disclosed is an injectable composition for restoring of age related tissue loss in the face and selected areas of the body, which contains a growth factor and hyaluronic acid as a carrier for providing time release of the growth factor into tissues. The growth factor can be insulin, insulin-like growth factor, thyroid hormone, fibroblast growth factor, estrogen, retinoic acid, or their combinations.

Claims (16)

1. An injectable composition for restoring tissue volume, skin turgor, texture and tightness in the face or selected areas of the body of a person, comprising liothyronine sodium, levothyroxine sodium, insulin, and hyaluronic acid, wherein said hyaluronic acid has a concentration from 0.5 g to 3 g per 100 ml of said composition.

2. The injectable composition of claim 1 , wherein said liothyronine sodium has a concentration from 2 μg to 30 μg per 100 ml of said composition.

3. The injectable composition of claim 1 , wherein said levothyroxine sodium has a concentration from 10 μg to 60 μg per 100 ml of said composition.

4. The injectable composition of claim 1 , wherein said insulin has a concentration from 5 units to 40 units per 100 ml of said composition.

5. The injectable composition of claim 1 further comprising retinoic acid.

6. The injectable composition of claim 5 , wherein said retinoic acid has a concentration from 5 mg to 25 mg per 100 ml of said composition.

7. The injectable composition of claim 1 further comprising dimethylaminoethanol.

8. An injectable composition for restoring tissue volume, skin turgor, texture and tightness in the face or selected areas of the body of a person, comprising:

2 μg to 30 μg of liothyronine sodium,

10 μg to 60 μg of levothyroxine sodium,

5 units to 40 units of insulin, and

0.5 g to 3 g of hyaluronic acid,

per 100 ml of said composition.

9. The injectable composition of claim 8 further comprising 5 mg to 25 mg of retinoic acid per 100 ml of said composition.

10. The injectable composition of claim 8 further comprising deuterium-reduced water.

11. The injectable composition of claim 8 further comprising dimethylaminoethanol.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2014
From: GIAMPAPA, VINCENT, M.D.
To: LIFE SCIENCE INSTITUTE, LLC.
Reel/Frame 032337/0291 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2014
From: LIFE SCIENCE INSTITUTE, LLC.
To: CELLHEALTH TECHNOLOGIES LTD.
Reel/Frame 032337/0806 →
Continuity (3)
Division 11241005 · Oct 1, 2005
Provisional Application 60615164 · Oct 1, 2004
Related Publication 20080274946A1 · Nov 6, 2008